IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
